Pfizer (PFE) Breaks to a 52-Week High at $28.24, Clearing the April Peak
As seen on the 24/7 Wall St. homepage on August 19, 2026.
Pfizer closed at $28.24, a new 52-week high that clears the April 1 peak. The drugmaker has now taken out the ceiling that capped it all spring, making that old level the line to defend.
Continue ReadingShow less
Pfizer closed at $28.24 on August 19, a fresh 52-week high that clears the April 1 ceiling which capped every rally since spring. That old peak is now the first support the stock has to defend.
Keep an eye on the stock: if this close fails to hold above the former peak, traders treat the breakout as a failed signal.
Disclosure
*$149 for two years (or $1.43 per week) is an introductory promotion for new members only. 62% discount based on the current list price of Stock Advisor of $199/year. Membership will renew at the then-current list price at the end of the membership term. Stock Advisor returns are 930% as compared to the S&P 500 returns of 185% as of April 7, 2026.
The same investor newsletter that told subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005 still publishes two new stock picks every month. Over 23 years, Motley Fool's Stock Advisor has more than quadrupled the S&P 500. New members get this month's picks, the Top 10 Rankings, and a 30-day money-back guarantee. Click here to unlock their next top stocks while new members are still being accepted.
The days following this close matter as much as the close itself.
The immediate question for investors is whether this close holds and whether volume confirms the move. A breakout that fades back below the former peak quickly is often treated as a failed signal, so the days following this close matter as much as the close itself.
Sources
Mentioned: PFE